These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 33560108)

  • 1. CRISPRi-Mediated NIMPLY Logic Gate for Fine-Tuning the Whole-Cell Sensing toward Simple Urine Glucose Detection.
    Tan SI; Ng IS
    ACS Synth Biol; 2021 Feb; 10(2):412-421. PubMed ID: 33560108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Insight into Plasmid-Driven T7 RNA Polymerase in
    Tan SI; Ng IS
    ACS Synth Biol; 2020 Mar; 9(3):613-622. PubMed ID: 32142603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Transcriptional Repression in Bacteria Using CRISPR Interference (CRISPRi).
    Hawkins JS; Wong S; Peters JM; Almeida R; Qi LS
    Methods Mol Biol; 2015; 1311():349-62. PubMed ID: 25981485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A plasmid toolset for CRISPR-mediated genome editing and CRISPRi gene regulation in Escherichia coli.
    Jervis AJ; Hanko EKR; Dunstan MS; Robinson CJ; Takano E; Scrutton NS
    Microb Biotechnol; 2021 May; 14(3):1120-1129. PubMed ID: 33710766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redirecting Metabolic Flux via Combinatorial Multiplex CRISPRi-Mediated Repression for Isopentenol Production in Escherichia coli.
    Tian T; Kang JW; Kang A; Lee TS
    ACS Synth Biol; 2019 Feb; 8(2):391-402. PubMed ID: 30681833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic manipulation through CRISPRi and gene deletion to enhance cadaverine production in Escherichia coli.
    Ting WW; Ng IS
    J Biosci Bioeng; 2020 Dec; 130(6):553-562. PubMed ID: 32792329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible Gene Expression Control in Yersinia pestis by Using an Optimized CRISPR Interference System.
    Wang T; Wang M; Zhang Q; Cao S; Li X; Qi Z; Tan Y; You Y; Bi Y; Song Y; Yang R; Du Z
    Appl Environ Microbiol; 2019 Jun; 85(12):. PubMed ID: 30979834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPRi-mediated programming essential gene can as a Direct Enzymatic Performance Evaluation & Determination (DEPEND) system.
    Tan SI; Yu PJ; Ng IS
    Biotechnol Bioeng; 2020 Sep; 117(9):2842-2851. PubMed ID: 32458463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR interference-guided multiplex repression of endogenous competing pathway genes for redirecting metabolic flux in Escherichia coli.
    Kim SK; Seong W; Han GH; Lee DH; Lee SG
    Microb Cell Fact; 2017 Nov; 16(1):188. PubMed ID: 29100516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient Transcriptional Gene Repression by Type V-A CRISPR-Cpf1 from Eubacterium eligens.
    Kim SK; Kim H; Ahn WC; Park KH; Woo EJ; Lee DH; Lee SG
    ACS Synth Biol; 2017 Jul; 6(7):1273-1282. PubMed ID: 28375596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering an Optogenetic CRISPRi Platform for Improved Chemical Production.
    Wu P; Chen Y; Liu M; Xiao G; Yuan J
    ACS Synth Biol; 2021 Jan; 10(1):125-131. PubMed ID: 33356154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multistable and dynamic CRISPRi-based synthetic circuits.
    Santos-Moreno J; Tasiudi E; Stelling J; Schaerli Y
    Nat Commun; 2020 Jun; 11(1):2746. PubMed ID: 32488086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programmable Gene Knockdown in Diverse Bacteria Using Mobile-CRISPRi.
    Banta AB; Ward RD; Tran JS; Bacon EE; Peters JM
    Curr Protoc Microbiol; 2020 Dec; 59(1):e130. PubMed ID: 33332762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Cas Expands Dynamic Range of Gene Expression From T7RNAP Promoters.
    McCutcheon SR; Chiu KL; Lewis DD; Tan C
    Biotechnol J; 2018 May; 13(5):e1700167. PubMed ID: 29149479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applications of CRISPR/Cas System to Bacterial Metabolic Engineering.
    Cho S; Shin J; Cho BK
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29621180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of CRISPRi for prokaryotic metabolic engineering involving multiple genes, a case study: Controllable P(3HB-co-4HB) biosynthesis.
    Lv L; Ren YL; Chen JC; Wu Q; Chen GQ
    Metab Eng; 2015 May; 29():160-168. PubMed ID: 25838211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine tuning the glycolytic flux ratio of EP-bifido pathway for mevalonate production by enhancing glucose-6-phosphate dehydrogenase (Zwf) and CRISPRi suppressing 6-phosphofructose kinase (PfkA) in Escherichia coli.
    Li Y; Xian H; Xu Y; Zhu Y; Sun Z; Wang Q; Qi Q
    Microb Cell Fact; 2021 Feb; 20(1):32. PubMed ID: 33531004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR interference-mediated gene regulation in Pseudomonas putida KT2440.
    Kim SK; Yoon PK; Kim SJ; Woo SG; Rha E; Lee H; Yeom SJ; Kim H; Lee DH; Lee SG
    Microb Biotechnol; 2020 Jan; 13(1):210-221. PubMed ID: 30793496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of a programmable biosensor-CRISPRi genetic circuits for dynamic and autonomous dual-control of metabolic flux in Bacillus subtilis.
    Wu Y; Chen T; Liu Y; Tian R; Lv X; Li J; Du G; Chen J; Ledesma-Amaro R; Liu L
    Nucleic Acids Res; 2020 Jan; 48(2):996-1009. PubMed ID: 31799627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing and Assembling Plasmids for the Construction of Escherichia coli Biosensor for Vibrio cholerae Detection.
    Holowko MB; Poh CL
    Methods Mol Biol; 2018; 1772():445-456. PubMed ID: 29754245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.